Ages2Come
Menu
View all results →
Categories
⚡ Breaking
Japanese green tea giant Ito En surges 8%, defying a broad market sell-off Australia posts second-quarter growth of 2.1%, beating expectations Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group Massachusetts’ 80-year-old senator sees off primary challenge over his age Pentagon chaos deepens after Driscoll quits in clash with Hegseth Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading Japanese green tea giant Ito En surges 8%, defying a broad market sell-off Australia posts second-quarter growth of 2.1%, beating expectations Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group Massachusetts’ 80-year-old senator sees off primary challenge over his age Pentagon chaos deepens after Driscoll quits in clash with Hegseth Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading
Economy Economy

‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

Source: cnbc June 3, 2026 · 22:45
Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking in 2026 is off to a strong start.
Read original article ← Back to Economy

The original article opens on the publisher's website.

More from Economy

View topic →